In addition to literature supporting the BioACL™ technique’s ability to significantly decrease tunnel widening in ACL reconstruction (ACLR),[1] a peer-reviewed study reported high rates of return to preinjury activity and low graft rerupture rates at 2 years postoperative.[2]
The BioACL technique uses customized concentrated platelet-rich plasma from bone marrow aspirate mixed with autologous bone and AlloSync™ Pure demineralized bone matrix to augment bone tunnels created during ACLRs, using the patient’s own biology to support healing potential.
Read the full article:
arthrex.info/4x1clHx
1. Lavender CD, et al. Arthroscopy. 2025;41(5):1496-1508. doi:10.1016/j.arthro.2024.06.042
2. Peterson, J., et al. Arthrosc Sports Med Rehabil. 2026;8:e70023. doi:10.1002/ars2.70023